Human papillomavirus genotype distribution in cervical samples collected in routine clinical practice at the Nantes University Hospital, France.
OBJECTIVE
The objective was to assess the human papillomavirus (HPV) overall and type-specific prevalence in smears collected during routine clinical practice.


METHODS
HPV genotyping and smears were performed independently between 2000 and 2006 for routine clinical follow-up (primary screening and follow-up) in the University Hospital of Nantes, France.


METHODS
All women with a cytological sample collected no more than 12 months before HPV genotyping were included.


METHODS
PCR was performed with MY09/MY11 primers and genotyping by sequencing PCR product.


METHODS
Overall and genotype-specific HPV prevalence were assessed according to cytological diagnosis.


RESULTS
A total of 1,255 women were included (mean age 37.5 years). The proportion of high-risk (HR) HPV positive samples increased according to cytological diagnosis severity from 8% in normal specimens to 21% in atypical squamous cells of undetermined significance, 49% in low-grade squamous intraepithelial lesion and 75% in high-grade squamous intraepithelial lesion (HSIL) (p < 0.001). Among 980 women with normal cytology, the overall HPV prevalence varied according to age from 44% below 20 years to about 10% above 35 years (p < 0.001). The most prevalent HPV genotype in all cytological diagnoses was HPV 16. HPV 53 appeared as the second most common genotype in normal cytological samples (10.9% of HPV positive samples) but its prevalence decreased in HSIL to less than 4%.


CONCLUSIONS
The proportion of HR HPV positive women increased according to cytological diagnosis severity. HPV 16 appeared as the most commonly encountered genotype even when the diagnosis was normal. Its prevalence increased with diagnosis severity hereby confirming that HPV 16 is more aggressive than other genotypes.
CHU de Nantes, Pôle Mère-Enfant, Service de Gynécologie Obstétrique et Médecine de la Reproduction, 7 quai Moncousu, 44093, Nantes Cedex 1, France.
Edouard
E
Vaucel
Marianne
M
Coste-Burel
Christian
C
Laboisse
André
A
Dahlab
Patrice
P
Lopes
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D017931:DNA Primers; D005260:Female; D005602:France / Q000453:epidemiology; D005838:Genotype; D006785:Hospitals, University; D052162:Human papillomavirus 16 / Q000235:genetics; D006801:Humans; D008875:Middle Aged; D009367:Neoplasm Staging; D027383:Papillomaviridae / Q000235:genetics*; D030361:Papillomavirus Infections / Q000453:epidemiology / Q000473:pathology / Q000821:virology*; D016133:Polymerase Chain Reaction; D015995:Prevalence; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology / Q000473:pathology / Q000821:virology*; D014626:Vaginal Smears; D055815:Young Adult; D002578:Uterine Cervical Dysplasia / Q000453:epidemiology / Q000473:pathology / Q000821:virology*
D017931:DNA Primers